Bill Text: NY A07979 | 2017-2018 | General Assembly | Amended
Bill Title: Prohibits certain insurance policies from requiring prior authorization for buprenorphine products, methadone and long acting injectable naltrexone for detoxification or maintenance treatment of substance use disorders.
Spectrum: Partisan Bill (Democrat 2-0)
Status: (Engrossed - Dead) 2018-03-26 - REFERRED TO INSURANCE [A07979 Detail]
Download: New_York-2017-A07979-Amended.html
STATE OF NEW YORK ________________________________________________________________________ 7979--A 2017-2018 Regular Sessions IN ASSEMBLY May 23, 2017 ___________ Introduced by M. of A. QUART -- read once and referred to the Committee on Insurance -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee AN ACT to amend the insurance law, in relation to prohibiting certain insurance policies from requiring prior authorization for certain medications used in the treatment of substance use disorders; and to repeal certain provisions of such law relating thereto The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Paragraph 31-a of subsection (i) of section 3216 of the 2 insurance law is REPEALED and a new paragraph 31-a is added to read as 3 follows: 4 (31-a) (A) No policy that provides medical, major medical or similar 5 comprehensive-type coverage and provides coverage for prescription drugs 6 for medication for the treatment of a substance use disorder shall 7 require prior authorization for an initial or renewal prescription for 8 all buprenorphine products, methadone or long acting injectable naltrex- 9 one for detoxification or maintenance treatment of a substance use 10 disorder except where otherwise prohibited by law. 11 (B) Coverage provided under this paragraph may be subject to copay- 12 ments, coinsurance, and annual deductibles that are consistent with 13 those imposed on other benefits within the policy. 14 § 2. Paragraphs 7-a and 7-b of subsection (l) of section 3221 of the 15 insurance law are REPEALED and a new paragraph 7-a is added to read as 16 follows: 17 (7-a) (A) Every policy that provides medical, major medical or similar 18 comprehensive-type large group coverage shall provide immediate coverage 19 for all buprenorphine products, methadone or long acting injectable 20 naltrexone without prior authorization for the detoxification or mainte- 21 nance treatment of a substance use disorder. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD11793-02-7A. 7979--A 2 1 (B) Coverage provided under this paragraph may be subject to copay- 2 ments, coinsurance, and annual deductibles that are consistent with 3 those imposed on other benefits within the policy. 4 § 3. Subsections (l-1) and (l-2) of section 4303 of the insurance law 5 are REPEALED and a new subsection (l-1) is added to read as follows: 6 (l-1) (A) Every contract that provides medical, major medical, or 7 similar comprehensive-type large group coverage shall provide immediate 8 coverage for all buprenorphine products, methadone or long acting 9 injectable naltrexone without prior authorization for the detoxification 10 or maintenance treatment of a substance use disorder. 11 (B) Coverage provided under this paragraph may be subject to copay- 12 ments, coinsurance, and annual deductibles that are consistent with 13 those imposed on other benefits within the policy. 14 § 4. This act shall take effect on the sixtieth day after it shall 15 have become a law.